Back to results
CompletedPhase 1

IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma

NCT00349934

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Hôpital Européen Georges Pompidou

Paris, France

+2 additional locations

View on ClinicalTrials.gov
IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma — TrialFind